{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:28:46Z","timestamp":1773692926929,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.expneurol.2010.07.015","type":"journal-article","created":{"date-parts":[[2010,7,25]],"date-time":"2010-07-25T08:53:20Z","timestamp":1280048000000},"page":"402-407","source":"Crossref","is-referenced-by-count":16,"title":["Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6\/2 model of Huntington disease"],"prefix":"10.1016","volume":"225","author":[{"given":"Sara J.","family":"Tallaksen-Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Janiszewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasha","family":"Benton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lech","family":"Ruprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.07.015_bb0005","series-title":"Neurodegenerative Brain Disorders","first-page":"259","article-title":"Huntington disease: a model excitotoxic chronic neurodegeneration","author":"Bazzett","year":"2001"},{"issue":"5","key":"10.1016\/j.expneurol.2010.07.015_bb0010","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0028-3908(98)00218-4","article-title":"Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn","volume":"38","author":"Boyce","year":"1999","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.expneurol.2010.07.015_bb0015","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1124\/jpet.105.084467","article-title":"Effects of the N-methyl-d-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8, 9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity","volume":"313","author":"Brandt","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.expneurol.2010.07.015_bb0020","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0025","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2010.07.015_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0028-3908(01)00191-5","article-title":"Studies on the subtype selectivity of CP-101,606: evidence for two classes of NR2B-selective NMDA receptor antagonists","volume":"42","author":"Chazot","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0035","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J. Neurochem."},{"issue":"5574","key":"10.1016\/j.expneurol.2010.07.015_bb0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.expneurol.2010.07.015_bb0050","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0055","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinate acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0060","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioral deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"Pt 6","key":"10.1016\/j.expneurol.2010.07.015_bb0065","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0371147","article-title":"Coupling of the NMDA receptor to neuroprotective and neurodestructive events","volume":"37","author":"Hardingham","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2010.07.015_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2008.06.005","article-title":"Rodent genetic models of Huntington disease","volume":"32","author":"Heng","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0080","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2010.07.015_bb0280","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.expneurol.2010.07.015_bb0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.expneurol.2010.07.015_bb0090","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/jm970504g","article-title":"Design and synthesis of [2-(8, 9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid (EAA-090), a potent N-methyl-d-aspartate antagonist, via the use of 3-cyclobutene-1, 2-dione as an achiral alpha-amino acid bioisostere","volume":"41","author":"Kinney","year":"1998","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.expneurol.2010.07.015_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I","article-title":"Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum","volume":"419","author":"K\u00fcppenbender","year":"2000","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0100","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1096\/fj.08-107268","article-title":"Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors","volume":"22","author":"Leveille","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.expneurol.2010.07.015_bb0105","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1523\/JNEUROSCI.5115-09.2010","article-title":"Suppression of the intrinsic apoptosis pathway by synaptic activity","volume":"30","author":"L\u00e9veill\u00e9","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0120","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1152\/jn.00308.2004","article-title":"Enhanced striatal NR2B-containing N-methyl-d-aspartate receptor-mediated synaptic currents in a mouse model of Huntington's disease","volume":"92","author":"Li","year":"2004","journal-title":"J. Neurophysiol."},{"issue":"7188","key":"10.1016\/j.expneurol.2010.07.015_bb0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nature06731","article-title":"Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1","volume":"452","author":"Lim","year":"2008","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.expneurol.2010.07.015_bb0130","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.0116-07.2007","article-title":"NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo","volume":"27","author":"Liu","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(02)00302-9","article-title":"The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications","volume":"97","author":"Loftis","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0140","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroscience.2008.01.080","article-title":"In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death","volume":"158","author":"Martel","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0145","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"McGeer","year":"1976","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.expneurol.2010.07.015_bb0150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.expneurol.2010.07.015_bb0155","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0028-3908(99)00211-7","article-title":"CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents","volume":"39","author":"Menniti","year":"2000","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.expneurol.2010.07.015_bb0160","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.expneurol.2010.07.015_bb0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.expneurol.2010.07.015_bb0170","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/3661","article-title":"Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition","volume":"1","author":"Mott","year":"1998","journal-title":"Nat. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2010.07.015_bb0175","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0014-2999(00)00263-6","article-title":"Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro","volume":"397","author":"Murray","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.expneurol.2010.07.015_bb0180","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/mds.22169","article-title":"Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism","volume":"23","author":"Nutt","year":"2008","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.expneurol.2010.07.015_bb0185","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nm.2056","article-title":"Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin","volume":"15","author":"Okamoto","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0190","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.expneurol.2010.07.015_bb0195","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nn2071","article-title":"Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses","volume":"11","author":"Papadia","year":"2008","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.expneurol.2010.07.015_bb0200","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"Pt 4","key":"10.1016\/j.expneurol.2010.07.015_bb0205","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.nbd.2005.08.001","article-title":"Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease","volume":"21","author":"Shehadeh","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.expneurol.2010.07.015_bb0215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2009.09.002","article-title":"Glutamate-based antidepressants: 20years on","volume":"30","author":"Skolnick","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.expneurol.2010.07.015_bb0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"issue":"47","key":"10.1016\/j.expneurol.2010.07.015_bb0225","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2010.07.015_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0169-328X(98)00293-9","article-title":"Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat","volume":"64","author":"Standaert","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"24","key":"10.1016\/j.expneurol.2010.07.015_bb0235","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1073\/pnas.0903546106","article-title":"Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity","volume":"106","author":"Stanika","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.expneurol.2010.07.015_bb0240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/jpet.104.066092","article-title":"Characterization of two novel N-methyl-d-aspartate antagonists: EAA-090 (2-[8, 9-dioxo-2, 6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride)","volume":"310","author":"Sun","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.expneurol.2010.07.015_bb0245","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1523\/JNEUROSCI.19-10-04180.1999","article-title":"The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro","volume":"19","author":"Tovar","year":"1999","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.expneurol.2010.07.015_bb0250","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0255","author":"Warby"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1073858404269012","article-title":"N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease","volume":"11","author":"Waxman","year":"2005","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2010.07.015_bb0270","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2010.07.015_bb0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T16:01:30Z","timestamp":1559318490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610002530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0014488610002530"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.07.015","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}